Applying to Clinical Trial: A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Contact this trialFirst, we need to learn more about you.

Cancer Vaccine

FLU HD vaccine +1 More for Respiratory Syncytial Virus

Recruiting2 awardsPhase 3

Orlando, Florida

This trial is testing a new RSV vaccine and a high-dose flu shot in adults aged 65 and older. The goal is to see if giving both vaccines together is safe and effective. Both vaccines work by helping the immune system recognize and fight off these viruses. High-dose influenza vaccines have been shown to provide better protection against influenza infection in persons aged 65 years and above compared to standard-dose vaccines.

Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.

We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our and .

Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.

By clicking start, you agree to our